NASDAQ
DarioHealth Corp. (DRIO) has a price/sales ratio of 25.26x as of Friday, May 22, 2026. This represents a 71.49% decrease compared to its 12-month average of 88.61x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.